CRNX Disposition Disclosure
Kalofonos Isabel · SEC Form 4 · Filed Sep 1, 2026
Disposition
Calculated transaction value
$2.89M
Kalofonos Isabel Chief Commercial Officer
CRNX
Transaction date
Sep 1, 2026
Public filing date
Sep 1, 2026
Filing lag
Filed same day
CRNX daily price context
Close on/before transaction
$84.95
Sep 1, 2026
Close before public filing
$84.95
Aug 31, 2026
Return since public filing
0.0%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 34,000 shares @ $85
- SEC ownership
- Direct
- Transaction code
- D
- Form
- 4
- Filing identifier
- 0001628280-26-059885
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$9.63M
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Crinetics Pharmaceuticals, Inc. CRNX | Disposition | Sep 1, 2026 | $141.87K |
| Crinetics Pharmaceuticals, Inc. CRNX Current | Disposition | Sep 1, 2026 | $2.89M |
| Crinetics Pharmaceuticals, Inc. CRNX | Disposition | Sep 1, 2026 | $4.33M |
| Crinetics Pharmaceuticals, Inc. CRNX | Disposition | Sep 1, 2026 | $2.27M |